21/05/2026 22:17
|
Medical, Health & Aged Care
* Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC)
* CEACAM5 is overexpressed in the majority of...